Fenbendazole & Cancer

Therapy Safety Protocols

Fenbendazole & Cancer's avatar
Fenbendazole & Cancer
Nov 12, 2026
∙ Paid

According to the source material, because self-medication carries risks such as organ strain, drug-induced toxicities, and potential interactions, the following safety monitoring protocols and tests are recommended and documented during treatment with repurposed antiparasitics (such as fenbendazole, ivermectin, and mebendazole):

1. Routine Blood Panels & Organ Function Testing

  • Liver Function Tests (LFTs / Hepatic Panel):

    • Tracking liver enzymes (ALT, AST, bilirubin, and alkaline phosphatase) is essential.

    • Unmonitored self-treatment carries a risk of liver toxicity and elevated enzymes (transaminitis).

    • Case reports note that transient liver enzyme spikes can occasionally occur during therapy (sometimes reflecting metabolic stress or tumor lysis rather than direct drug-induced hepatotoxicity), making serial blood panels crucial to ensure levels normalize and avoid organ injury.

User's avatar

Continue reading this post for free, courtesy of Fenbendazole & Cancer.

Or purchase a paid subscription.
© 2026 Fenbendazole & Cancer · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.